Filing Details
- Accession Number:
- 0001127602-13-017835
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-22 15:26:49
- Reporting Period:
- 2013-05-20
- Filing Date:
- 2013-05-22
- Accepted Time:
- 2013-05-22 15:26:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
912183 | Cubist Pharmaceuticals Inc | CBST | Pharmaceutical Preparations (2834) | 223192085 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1219016 | W Michael Bonney | 65 Hayden Avenue Lexington MA 02421 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-05-20 | 60,000 | $12.61 | 221,518 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-05-20 | 60,000 | $50.00 | 161,518 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2013-05-20 | 60,000 | $0.00 | 60,000 | $12.61 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2004-03-12 | 2013-12-12 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 6,603 | Indirect | 401(k) Plan |
Common Stock | 600 | Indirect | Trusts |
Footnotes
- Sold pursuant to a 10(b)5-1 Plan
- This transaction was executed in multiple trades at prices ranging from $50.00 to $50.04. The price reported in the table reflects the weighted average sale price. The reporting person undertakes to privde upon request to the SEC staff, the issuer or a secruity holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Option vests 6.25% quarterly over a four-year period.